Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00007540
Status:
COMPLETED
Last Update Posted:
2009-01-21
First Post:
2000-12-29
Brief Title:
Study of Prostate Cancer in Black and White US Veterans
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Study of Prostate Cancer in Black and White US Veterans
Status:
COMPLETED
Status Verified Date:
2003-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Prostate cancer is diagnosed in approximately 334500 men each year and accounts for nearly 41800 deaths in the United States Prostate cancer is the leading cancer affecting veterans and the second leading cancer among all Americans The causes of prostate cancer and particularly the reasons for the unusually high incidence rates in African-Americans remain obscure Dietary factors likely play a role in fatal cases while hormones are also important in regulating prostate cancer growth Dr Charles Huggins recognized this effect in the 1940s with androgen deprivation remaining as the cornerstone of therapy for advanced disease Despite the strong circumstantial evidence neither epidemiologic studies nor basic sciences have produced clear insight into the etiologic role of hormones However recent observations regarding androgen receptor gene polymorphisms and their relation to endocrine expression and prostate cancer risk may be providing important clues as to how an etiologic role might be mediated at the molecular level Thus it is important to attempt to identify genetic markers of high-risk cancer patients for necessary screening and counseling efforts
Detailed Description:
Primary Objectives To evaluate the relationship between the length of the CAG repeat sequence occurring in the androgen receptor gene and major prostate cancer prognostic determinants race age histologic grade and stage at the time of diagnosis in black and white veterans
Secondary Objectives To create a secure organized bank of DNA plasma samples obtained from newly diagnosed prostate cancer patients and assay the peripheral blood DNA for inherited polymorphisms of the androgen receptor gene
Primary Outcomes The primary outcomes are androgen receptor CAG repeat sequence length and stage of disease
Intervention NA
Study Abstract Prostate cancer is diagnosed in approximately 334500 men each year and accounts for nearly 41800 deaths in the United States Prostate cancer is the leading cancer affecting veterans and the second leading cancer among all Americans The causes of prostate cancer and particularly the reasons for the unusually high incidence rates in African-Americans remain obscure Dietary factors likely play a role in fatal cases while hormones are also important in regulating prostate cancer growth Dr Charles Huggins recognized this effect in the 1940s with androgen deprivation remaining as the cornerstone of therapy for advanced disease Despite the strong circumstantial evidence neither epidemiologic studies nor basic sciences have produced clear insight into the etiologic role of hormones However recent observations regarding androgen receptor gene polymorphisms and their relation to endocrine expression and prostate cancer risk may be providing important clues as to how an etiologic role might be mediated at the molecular level Thus it is important to attempt to identify genetic markers of high-risk cancer patients for necessary screening and counseling efforts
It has been recently demonstrated that the androgen receptor functions as a ligand-dependent transcriptional regulator and that this regulation is important in controlling prostate growth and apoptosis Heightened androgenic stimulation a potential by-product of shortened CAG repeat length could potentially increase the risk of prostate cancer development and progression In particular a shorter CAG repeat sequence may be associated with cancers that have features of higher histologic grade extraprostatic extension and distant metastases stage C or D Recent evidence indicates that men with shorter CAG repeats are at particularly higher risk for distant metastatic and fatal prostate cancer The results demonstrated that a shorter CAG repeat sequence in the androgen receptor gene predicted higher grade and advanced state of prostate cancer at diagnosis metastatic disease and mortality However these studies have been limited to whites since only a small number of African American men with prostate cancer were included
Prostate cancer incidence varies between African-American and white men African-American men have the highest known incidence rates in the world 66 higher than white men in the US The genetic findings described above raise the possibility that racial differences in the distribution of androgen receptor polymorphisms may account for the higher rate of prostate cancer the more advanced disease and the younger age at presentation in African-Americans
This study created a cohort of prostate cancer patients who are well characterized with respect to histology stage of diagnosis and over time mortality This study is generating data regarding the length of the CAG repeat sequence occurring in the androgen receptor gene and major prostate cancer prognostic determinants histologic grade and state at the time of diagnosis in black and white veterans CAG repeat lengths on the androgen receptor gene were evaluated for a cohort of 145 African American and 150 white veterans with prostate cancer
Results Mean androgen receptor gene CAG repeat lengths for Caucasians was 219 versus 198 for African Americans p00001 However a truncated CAG repeat length CAG 18 versus CAG 18 was not associated with advanced stage of cancer at diagnosis higher PSA at diagnosis or higher Gleason score each with p05
Conclusion The mean androgen receptor CAG repeat length was 2 repeats shorter for African American versus white prostate cancer patients These findings raise concern that prostate cancers in African American men may be less sensitive to hormonal therapy than those in white men These findings provide biologic rationale for clinical trials that evaluate the joint administration of chemotherapy and hormone therapy for African American men with advanced prostate cancer
Secondary Objectives To create a secure organized bank of DNA plasma samples obtained from newly diagnosed prostate cancer patients and assay the peripheral blood DNA for inherited polymorphisms of the androgen receptor gene
Primary Outcomes The primary outcomes are androgen receptor CAG repeat sequence length and stage of disease
Intervention NA
Study Abstract Prostate cancer is diagnosed in approximately 334500 men each year and accounts for nearly 41800 deaths in the United States Prostate cancer is the leading cancer affecting veterans and the second leading cancer among all Americans The causes of prostate cancer and particularly the reasons for the unusually high incidence rates in African-Americans remain obscure Dietary factors likely play a role in fatal cases while hormones are also important in regulating prostate cancer growth Dr Charles Huggins recognized this effect in the 1940s with androgen deprivation remaining as the cornerstone of therapy for advanced disease Despite the strong circumstantial evidence neither epidemiologic studies nor basic sciences have produced clear insight into the etiologic role of hormones However recent observations regarding androgen receptor gene polymorphisms and their relation to endocrine expression and prostate cancer risk may be providing important clues as to how an etiologic role might be mediated at the molecular level Thus it is important to attempt to identify genetic markers of high-risk cancer patients for necessary screening and counseling efforts
It has been recently demonstrated that the androgen receptor functions as a ligand-dependent transcriptional regulator and that this regulation is important in controlling prostate growth and apoptosis Heightened androgenic stimulation a potential by-product of shortened CAG repeat length could potentially increase the risk of prostate cancer development and progression In particular a shorter CAG repeat sequence may be associated with cancers that have features of higher histologic grade extraprostatic extension and distant metastases stage C or D Recent evidence indicates that men with shorter CAG repeats are at particularly higher risk for distant metastatic and fatal prostate cancer The results demonstrated that a shorter CAG repeat sequence in the androgen receptor gene predicted higher grade and advanced state of prostate cancer at diagnosis metastatic disease and mortality However these studies have been limited to whites since only a small number of African American men with prostate cancer were included
Prostate cancer incidence varies between African-American and white men African-American men have the highest known incidence rates in the world 66 higher than white men in the US The genetic findings described above raise the possibility that racial differences in the distribution of androgen receptor polymorphisms may account for the higher rate of prostate cancer the more advanced disease and the younger age at presentation in African-Americans
This study created a cohort of prostate cancer patients who are well characterized with respect to histology stage of diagnosis and over time mortality This study is generating data regarding the length of the CAG repeat sequence occurring in the androgen receptor gene and major prostate cancer prognostic determinants histologic grade and state at the time of diagnosis in black and white veterans CAG repeat lengths on the androgen receptor gene were evaluated for a cohort of 145 African American and 150 white veterans with prostate cancer
Results Mean androgen receptor gene CAG repeat lengths for Caucasians was 219 versus 198 for African Americans p00001 However a truncated CAG repeat length CAG 18 versus CAG 18 was not associated with advanced stage of cancer at diagnosis higher PSA at diagnosis or higher Gleason score each with p05
Conclusion The mean androgen receptor CAG repeat length was 2 repeats shorter for African American versus white prostate cancer patients These findings raise concern that prostate cancers in African American men may be less sensitive to hormonal therapy than those in white men These findings provide biologic rationale for clinical trials that evaluate the joint administration of chemotherapy and hormone therapy for African American men with advanced prostate cancer
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: